Daiwa Securities Group Inc. Gritstone Bio, Inc. Transaction History

Daiwa Securities Group Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$1.77 - $4.34 $19,238 - $47,171	-10,869 Reduced 98.21%	198 $0
Q1 2022 Apr 29, 2022	BUY	$4.03 - $12.19 $13,750 - $41,592	3,412 Added 44.57%	11,067 $46,000
Q4 2021 Feb 03, 2022	BUY	$8.76 - $13.71 $67,057 - $104,950	7,655 New	7,655 $98,000
Q4 2020 Feb 04, 2021	SELL	$2.57 - $4.22 $519 - $852	-202 Closed	0 $0
Q4 2019 Jan 31, 2020	BUY	$7.07 - $11.61 $1,428 - $2,345	202 New	202 $2,000

35.4M

395K

132K

Ticker GRTS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,006,896
Market Cap $2.19M
Description
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

Stay updated on Daiwa Securities Group Inc. with notifications on news.